Analyst firms · BTIG · MDT

BTIG MDT price target and rating history

Medtronic plc. (MDT) · Health Care

BTIG rates Medtronic plc. (MDT) Buy with a $90 price target, as of its latest action on Jun 4, 2026. It has published 3 rating actions on MDT since December 2021, including 1 upgrade and 1 downgrade. Across 7 firms with a MDT price target in the last 12 months, the median target is $100. BTIG's $90 is 10% below that.

Current rating

Buy

Price target

$90

Median target, all firms

$100

Actions on MDT

3

BTIG price target on MDT

Every BTIG rating on MDT

• Jun 4, 2026
  UpgradeBTIG upgrades to Buy from Neutral, price target $90
• Jan 10, 2022
  DowngradeBTIG downgrades to Neutral from Buy
• Dec 17, 2021
  ReiterateBTIG cuts its price target to $128 from $138, keeps Buy

How other firms rate MDT

Each firm's latest rating and stated target in the last 12 months.

Questions about BTIG and MDT

What is BTIG's price target for MDT?

BTIG's latest stated price target for Medtronic plc. (MDT) is $90, from its action on Jun 4, 2026.

What is BTIG's rating on MDT?

BTIG rates MDT Buy, a bullish rating, as of Jun 4, 2026.

When did BTIG last change its view on MDT?

On Jun 4, 2026, BTIG upgrades to Buy from Neutral, price target $90.

How does BTIG's MDT target compare with other analysts?

Across 7 firms with a MDT price target in the last 12 months, the median target is $100. BTIG's $90 is 10% below that.

More MDT rating histories

• Barclays3
• Needham7
• UBS4
• Goldman Sachs4
• Citigroup6
• Wells Fargo6
• RBC Capital Markets3
• Oppenheimer4
• Morgan Stanley4
• Raymond James3
• Truist Securities3
• Credit Suisse3

All BTIG ratingsMDT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.